1.
Reply to Dr de Cassai et al
by Sanders, Rebecca A
Regional anesthesia and pain medicine, 2018, Vol.43 (5), p.557-557
2.
Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
by Świerczyńska-Krępa, Monika, MD, PhD
Journal of allergy and clinical immunology, 2014, Vol.134 (4), p.883-890
3.
Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature
by Rajan, Jessica P., MD
Journal of allergy and clinical immunology, 2014, Vol.135 (3), p.676-681.e1
4.
Prostaglandin D2 : A dominant mediator of aspirin-exacerbated respiratory disease
by Cahill, Katherine N., MD
Journal of allergy and clinical immunology, 2014, Vol.135 (1), p.245-252
5.
Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease
by Mitsui, Chihiro, MD
Journal of allergy and clinical immunology, 2015, Vol.137 (2), p.400-411
6.
Clinical and pathologic perspectives on aspirin sensitivity and asthma
by Stevenson, Donald D
Journal of allergy and clinical immunology, 2006, Vol.118 (4), p.773-786
7.
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial
by Collet, Jean-Philippe, Prof
The Lancet (British edition), 2014, Vol.384 (9954), p.1577-1585
8.
Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice
by Shi, Maohua, MD
Journal of allergy and clinical immunology, 2014, Vol.134 (5), p.1163-1174.e16
9.
Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease
by Cahill, Katherine N., MD
Journal of allergy and clinical immunology, 2016, Vol.139 (3), p.764-766
10.
Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease
by Eastman, Jacqueline J., MD
Journal of allergy and clinical immunology, 2016, Vol.140 (1), p.101-108.e3
11.
Platelets in patients with aspirin-exacerbated respiratory disease
by Laidlaw, Tanya M., MD
Journal of allergy and clinical immunology, 2015, Vol.135 (6), p.1407-1414
12.
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease
by Lee, Jennifer Y., MD
Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.157-164
13.
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease
by Buchheit, Kathleen M., MD
Journal of allergy and clinical immunology, 2015, Vol.137 (5), p.1566-1576.e5
14.
Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease
by Steinke, John W., PhD
Journal of allergy and clinical immunology, 2013, Vol.132 (4), p.856-865.e3
15.
Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease
by Bochenek, Grazyna
Respiratory medicine, 2015, Vol.109 (5), p.588-595
16.
Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis
by Bochenek, Grazyna, MD, PhD
Journal of allergy and clinical immunology, 2013, Vol.133 (1), p.98-103.e6
17.
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
by Li, Linxin, DPhil
The Lancet (British edition), 2017, Vol.390 (10093), p.490-499
18.
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
by Askie, Lisa M, Dr
The Lancet (British edition), 2007, Vol.369 (9575), p.1791-1798
19.
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
by Rothwell, Peter M, Prof
The Lancet (British edition), 2010, Vol.376 (9754), p.1741-1750
20.
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of...
by Morales, Daniel R., MBChB
Journal of allergy and clinical immunology, 2013, Vol.134 (1), p.40-45.e10
